STOCK TITAN

[144] US Physical Therapy Inc SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144
Rhea-AI Filing Summary

US Physical Therapy, Inc. (USPH) filed a Form 144 proposing the sale of 700 shares of common stock through Charles Schwab & Co., Inc. The filing lists an approximate sale date of 08/25/2025 and reports an aggregate market value of $60,119. It shows total shares outstanding of 15,204,119, indicating the proposed sale represents a very small fraction of the companys outstanding stock. The shares were acquired on 01/01/2025 as employee equity compensation (1,208 shares reported acquired). The filer reports no sales in the past three months.

US Physical Therapy, Inc. (USPH) ha presentato un Modulo 144 proponendo la vendita di 700 azioni ordinarie tramite Charles Schwab & Co., Inc. La comunicazione indica una data di vendita approssimativa del 25/08/2025 e riporta un valore di mercato complessivo di circa $60.119. Viene riportato un totale di azioni in circolazione pari a 15.204.119, pertanto la proposta rappresenta una porzione molto ridotta del capitale sociale della società. Le azioni sono state acquisite il 01/01/2025 come compenso azionario per dipendenti (1.208 azioni dichiarate acquisite). Il dichiarante segnala l'assenza di vendite negli ultimi tre mesi.

US Physical Therapy, Inc. (USPH) presentó un Formulario 144 proponiendo la venta de 700 acciones ordinarias a través de Charles Schwab & Co., Inc. La presentación señala una fecha aproximada de venta del 25/08/2025 y declara un valor de mercado agregado de $60,119. Se indica un total de acciones en circulación de 15,204,119, por lo que la venta propuesta representa una fracción muy pequeña del capital social de la compañía. Las acciones se adquirieron el 01/01/2025 como compensación accionaria para empleados (1,208 acciones reportadas). El declarante informa que no hubo ventas en los últimos tres meses.

US Physical Therapy, Inc. (USPH)는 Charles Schwab & Co., Inc.를 통해 보통주 700주 매각을 제안하는 Form 144를 제출했습니다. 제출서에는 대략적인 매각 예정일을 2025-08-25로 기재하고 있으며, 총 시가치로 $60,119를 보고하고 있습니다. 발행주식 총수는 15,204,119주로 기재되어 있어 제안된 매각은 회사의 발행주식 중 극히 일부분에 해당합니다. 해당 주식은 2025-01-01에 직원 주식 보상으로 취득되었으며(보고된 취득주식 수 1,208주), 제출인은 최근 세 달간 매각 실적이 없다고 보고했습니다.

US Physical Therapy, Inc. (USPH) a déposé un formulaire 144 proposant la vente de 700 actions ordinaires via Charles Schwab & Co., Inc. Le dépôt indique une date approximative de vente au 25/08/2025 et rapporte une valeur de marché totale de 60 119 $. Le nombre total d'actions en circulation est de 15 204 119, ce qui montre que la vente proposée représente une part très faible du capital social de la société. Les actions ont été acquises le 01/01/2025 en tant que rémunération en actions pour les employés (1 208 actions déclarées acquises). Le déclarant signale l'absence de ventes au cours des trois derniers mois.

US Physical Therapy, Inc. (USPH) reichte ein Formular 144 ein, in dem der Verkauf von 700 Stammaktien über Charles Schwab & Co., Inc. vorgeschlagen wird. Die Einreichung nennt ein voraussichtliches Verkaufsdatum am 25.08.2025 und gibt einen Gesamtmarktwert von $60.119 an. Es werden insgesamt 15.204.119 ausstehende Aktien angegeben, sodass der vorgeschlagene Verkauf nur einen sehr kleinen Anteil des Unternehmenskapitals darstellt. Die Aktien wurden am 01.01.2025 als Mitarbeiteraktienvergütung erworben (berichtet: 1.208 erworbene Aktien). Der Meldende berichtet über keine Verkäufe in den letzten drei Monaten.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Small insider sale notice; amount is immaterial relative to outstanding shares.

The Form 144 notifies the market of a proposed sale of 700 shares valued at $60,119 via Charles Schwab with an approximate trade date of 08/25/2025. Against 15.2 million shares outstanding, the position is negligible, suggesting limited market impact. The securities were acquired as employee equity compensation on 01/01/2025. No prior sales in the past three months are reported, which reduces concerns about accelerated insider liquidation.

TL;DR: Filing appears routine and compliant; standard attestation included.

The notice includes the required attestation that the seller is not aware of undisclosed material adverse information and references the Rule 10b5-1 plan language. Broker details and acquisition method are disclosed, and the filing indicates no recent sales to aggregate. From a compliance perspective, the form contains the standard disclosures expected for an insider sale arising from equity compensation.

US Physical Therapy, Inc. (USPH) ha presentato un Modulo 144 proponendo la vendita di 700 azioni ordinarie tramite Charles Schwab & Co., Inc. La comunicazione indica una data di vendita approssimativa del 25/08/2025 e riporta un valore di mercato complessivo di circa $60.119. Viene riportato un totale di azioni in circolazione pari a 15.204.119, pertanto la proposta rappresenta una porzione molto ridotta del capitale sociale della società. Le azioni sono state acquisite il 01/01/2025 come compenso azionario per dipendenti (1.208 azioni dichiarate acquisite). Il dichiarante segnala l'assenza di vendite negli ultimi tre mesi.

US Physical Therapy, Inc. (USPH) presentó un Formulario 144 proponiendo la venta de 700 acciones ordinarias a través de Charles Schwab & Co., Inc. La presentación señala una fecha aproximada de venta del 25/08/2025 y declara un valor de mercado agregado de $60,119. Se indica un total de acciones en circulación de 15,204,119, por lo que la venta propuesta representa una fracción muy pequeña del capital social de la compañía. Las acciones se adquirieron el 01/01/2025 como compensación accionaria para empleados (1,208 acciones reportadas). El declarante informa que no hubo ventas en los últimos tres meses.

US Physical Therapy, Inc. (USPH)는 Charles Schwab & Co., Inc.를 통해 보통주 700주 매각을 제안하는 Form 144를 제출했습니다. 제출서에는 대략적인 매각 예정일을 2025-08-25로 기재하고 있으며, 총 시가치로 $60,119를 보고하고 있습니다. 발행주식 총수는 15,204,119주로 기재되어 있어 제안된 매각은 회사의 발행주식 중 극히 일부분에 해당합니다. 해당 주식은 2025-01-01에 직원 주식 보상으로 취득되었으며(보고된 취득주식 수 1,208주), 제출인은 최근 세 달간 매각 실적이 없다고 보고했습니다.

US Physical Therapy, Inc. (USPH) a déposé un formulaire 144 proposant la vente de 700 actions ordinaires via Charles Schwab & Co., Inc. Le dépôt indique une date approximative de vente au 25/08/2025 et rapporte une valeur de marché totale de 60 119 $. Le nombre total d'actions en circulation est de 15 204 119, ce qui montre que la vente proposée représente une part très faible du capital social de la société. Les actions ont été acquises le 01/01/2025 en tant que rémunération en actions pour les employés (1 208 actions déclarées acquises). Le déclarant signale l'absence de ventes au cours des trois derniers mois.

US Physical Therapy, Inc. (USPH) reichte ein Formular 144 ein, in dem der Verkauf von 700 Stammaktien über Charles Schwab & Co., Inc. vorgeschlagen wird. Die Einreichung nennt ein voraussichtliches Verkaufsdatum am 25.08.2025 und gibt einen Gesamtmarktwert von $60.119 an. Es werden insgesamt 15.204.119 ausstehende Aktien angegeben, sodass der vorgeschlagene Verkauf nur einen sehr kleinen Anteil des Unternehmenskapitals darstellt. Die Aktien wurden am 01.01.2025 als Mitarbeiteraktienvergütung erworben (berichtet: 1.208 erworbene Aktien). Der Meldende berichtet über keine Verkäufe in den letzten drei Monaten.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does USPH's Form 144 disclose about the planned insider sale?

The Form 144 discloses a proposed sale of 700 shares of USPH common stock through Charles Schwab with an approximate sale date of 08/25/2025 and an aggregate market value of $60,119.

How large is the proposed sale relative to USPH outstanding shares?

The filing reports 15,204,119 shares outstanding; the proposed sale of 700 shares represents approximately 0.0046% of outstanding shares.

When and how were the shares being sold acquired?

The shares were acquired on 01/01/2025 as employee equity compensation, with 1,208 shares reported acquired on that date.

Did the filer report any sales of USPH securities in the prior three months?

No. The filing states "Nothing to Report" for securities sold during the past three months.

Does the Form 144 include standard attestations about material information?

Yes. The filer represents by signing that they do not know any material adverse information about the issuer that has not been publicly disclosed and references Rule 10b5-1 trading plan language.
U S Physical Therapy

NYSE:USPH

USPH Rankings

USPH Latest News

USPH Latest SEC Filings

USPH Stock Data

1.31B
14.90M
1.94%
105.69%
4.3%
Medical Care Facilities
Services-health Services
Link
United States
HOUSTON